The excipients, equipment, and API companies have joined forces on Inhalation Together, an initiative aimed at advancing dry-powder inhalation solutions.
GSK has confirmed its new UK plant will continue to supply the US with Ellipta inhalers after capacity at its facility in North Carolina comes online this year.
Copley Scientific expects the new version of its flow rate control technology for dry powder inhaler (DPI) testing to be in demand among both generic drug firms and pharmaceutical innovators.
Vectura and Innovata have announced they are merging in a deal
worth £128.8m with the objective of becoming UK's number one in the
pulmonary drug development sector.
AstraZeneca has launched new production lines at its production
facility in Dunkerque in northern France, following a 24 per cent
growth in its respiratory sales in 2003. The new lines will produce
aerosol-delivered medicines for...
